204 related articles for article (PubMed ID: 2140991)
1. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
[TBL] [Abstract][Full Text] [Related]
2. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
[TBL] [Abstract][Full Text] [Related]
3. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
[TBL] [Abstract][Full Text] [Related]
4. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
5. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
6. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
11. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Heffner LJ
J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
[TBL] [Abstract][Full Text] [Related]
12. [Study on the local estrogen biosynthesis in human uterine leiomyoma].
Urabe M; Yamamoto T; Naito K; Kitawaki J; Honjo H; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1229-36. PubMed ID: 2212823
[TBL] [Abstract][Full Text] [Related]
13. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
15. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
Wu X; Wang H; Englund K; Blanck A; Lindblom B; Sahlin L
Fertil Steril; 2002 Nov; 78(5):985-93. PubMed ID: 12413982
[TBL] [Abstract][Full Text] [Related]
16. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
18. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.
Wilson EA; Yang F; Rees ED
Obstet Gynecol; 1980 Jan; 55(1):20-4. PubMed ID: 7352057
[TBL] [Abstract][Full Text] [Related]
19. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells.
Pasqualini JR; Gelly C; Lecerf F
Breast Cancer Res Treat; 1986; 8(3):233-40. PubMed ID: 3036286
[TBL] [Abstract][Full Text] [Related]
20. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
